Coomeva Entidad Promotora de Salud Valuation

Is COOMEVAEPS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of COOMEVAEPS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate COOMEVAEPS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate COOMEVAEPS's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for COOMEVAEPS?

Key metric: As COOMEVAEPS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for COOMEVAEPS. This is calculated by dividing COOMEVAEPS's market cap by their current revenue.
What is COOMEVAEPS's PS Ratio?
PS Ratio	0.05x
Sales	Col$2.30t
Market Cap	Col$125.39b

COOMEVAEPS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.1x
Enterprise Value/EBITDA	-2.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does COOMEVAEPS's PS Ratio compare to its peers?

The above table shows the PS ratio for COOMEVAEPS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
MARLY Clínica de Marly	0.2x	n/a	Col$90.8b
P8A Cordlife Group	1.1x	n/a	S$40.0m
1B1 HC Surgical Specialists	2.2x	n/a	S$41.5m
6665 Healthconn	0.8x	n/a	NT$952.4m
COOMEVAEPS Coomeva Entidad Promotora de Salud	0.05x	n/a	Col$125.4b

Price-To-Sales vs Peers: COOMEVAEPS is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does COOMEVAEPS's PS Ratio compare vs other companies in the South American Healthcare Industry?

5 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	0.7x	9.6%
COOMEVAEPS Coomeva Entidad Promotora de Salud	0.05x	n/a	US$29.20m

5 Companies		Estimated Growth	Market Cap
Industry Avg.	0.7x	26.5%
COOMEVAEPS Coomeva Entidad Promotora de Salud	0.05x	n/a	US$29.20m

No more companies

Price-To-Sales vs Industry: COOMEVAEPS is good value based on its Price-To-Sales Ratio (0.1x) compared to the South American Healthcare industry average (1.1x).

Price to Sales Ratio vs Fair Ratio

What is COOMEVAEPS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

COOMEVAEPS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.05x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate COOMEVAEPS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.